+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction



A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction



American Journal Of Obstetrics & Gynecology. 175(1): 158-164



OBJECTIVE: Our purpose was to compare two dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and induction of labor. STUDY DESIGN: Five hundred twenty-two patients with indications for induction of labor and unfavorable cervices were randomly assigned to one of two dosing regimens of vaginally administered misoprostol. Twenty-five microgram tablets of misoprostol were placed in the posterior vaginal fornix either every 3 hours to a maximum of eight doses or every 6 hours to a maximum of four doses. The maximal period of cervical ripening was 24 hours regardless of the number of misoprostol doses administered. Medication was not given after either spontaneous rupture of membranes or the beginning of active labor. RESULTS: Among 522 patients enrolled, 261 were randomized to receive misoprostol every 3 hours and 261 to receive misoprostol every 6 hours. The average interval from start of induction to vaginal delivery was shorter in the 3-hour dosing group (903.3 +- 482.1 minutes) than in the 6-hour dosing group (1410.9 +- 869.1 minutes) (p lt 0.001). Oxytocin augmentation of labor occurred more commonly in the 6-hour dosing group (51.4%) than in the 3-hour dosing group (41.8%) (p lt 0.05). There were no significant differences between routes of delivery. Overall, 108 patients (20.8%) were delivered by cesarean section. There was a slightly higher prevalence of tachysystole (six or more uterine contractions in a 10-minute window for two consecutive 10-minute periods) in the 3-hour group (14.6%) than in the 6-hour group (11.2%), but this difference was not statistically different. There were no significant differences in the frequency of uterine hyperstimulation or hypertonus. There was no significant difference between groups in the frequency of abnormal fetal heart rate tracings, meconium passage, 1- or 5-minute Apgar scores lt 7, neonatal resuscitations, or admissions to the neonatal intensive care unit. CONCLUSIONS: Vaginally administered misoprostol is an effective agent for cervical ripening and induction of labor. Patients with the 6-hour dosing schedule had longer intervals to delivery, more frequently required oxytocin augmentation, and had more failed inductions than did patients with 3-hour dosing. Further investigation to characterize the safety of misoprostol is needed.

(PDF emailed within 0-6 h: $19.90)

Accession: 008031019

Download citation: RISBibTeXText

PMID: 8694043

DOI: 10.1016/s0002-9378(96)70267-3


Related references

Comparison of 25 and 50 g Vaginally Administered Misoprostol for Preinduction of Cervical Ripening and Labor Induction. Gynecologic and Obstetric Investigation 53(1): 16-21, 2002

Comparison of 25 and 50 mug vaginally administered misoprostol for preinduction of cervical ripening and labor induction. Gynecologic & Obstetric Investigation 53(1): 16-21, 2002

Comparison of 25 and 50 microg vaginally administered misoprostol for preinduction of cervical ripening and labor induction. Gynecologic and Obstetric Investigation 53(1): 16-21, 2002

Vaginally administered misoprostol versus the dinoprostone vaginal insert for preinduction cervical ripening and labor induction. American Journal of Obstetrics & Gynecology 176(1 PART 2): S113, 1997

A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. American Journal of Obstetrics & Gynecology 180(5): 1155-1160, 1999

A comparison of vaginally administered misoprostol with extraamniotic saline infusion for cervical ripening and labor induction. American Journal of Obstetrics & Gynecology 185(6 Supplement): S203, 2001

A comparison of vaginally administered misoprostol with extra-amniotic saline solution infusion for cervical ripening and labor induction. American Journal of Obstetrics & Gynecology 187(4): 847-852, 2002

A comparison of misoprostol and prostaglandin E-2 gel for preinduction cervical ripening and labor induction. American Journal Of Obstetrics & Gynecology. 172(6): 1804-1810, 1995

Randomized comparison of misoprostol and dinoprostone for preinduction cervical ripening and labor induction. Journal of the Formosan Medical Association 96(5): 366-369, 1997

Randomization of two dosing regimens of vaginal misoprostol for cervical ripening and labor induction in a low resource setting. Nigerian Journal of Clinical Practice 17(3): 287-291, 2014

A double-blind randomized trial of two dose regimens of misoprostol for cervical ripening and labor induction. Journal of Maternal-Fetal Medicine 8(3): 114-118, 1999

A comparative randomized study on effect of vaginally administered glyceryl trinitrate placebo on cervical ripening prior to induction of labor in overdue pregnancies. Indian Journal of Pharmacology 50(5): 260-265, 2019

Open Randomized Comparison of Prostaglandin E2 Given by Intracervical Gel or Vagitory for Preinduction Cervical Ripening and Induction of Labor. Obstetric and Gynecologic Survey 47(8): 537-538, 1992

Open randomized comparison of prostaglandin E2 given by intracervical gel or vagitory for preinduction cervical ripening and induction of labor. Acta Obstetricia et Gynecologica Scandinavica 70(7-8): 549-553, 1991

Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. American Journal of Obstetrics and Gynecology 185(4): 916-919, 2001